1
/
of
1
Elabscience
SKU:PKSH031823
Recombinant Human tPA/PLAT Protein
Recombinant Human tPA/PLAT Protein
Regular price
$612.00 USD
Regular price
Sale price
$612.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant Human TPA/PLAT Protein, a cutting-edge biotechnological advancement in the field of protein therapeutics. This meticulously engineered product is derived from recombinant DNA technology, ensuring the highest level of purity and efficacy.
The Recombinant Human TPA/PLAT Protein is a potent activator of the fibrinolytic system, specifically targeting the conversion of plasminogen to plasmin. This enzymatic activity plays a crucial role in the dissolution of blood clots, making it an indispensable tool in the treatment of thrombotic disorders.
With its exceptional specificity and affinity for fibrin, this protein exhibits remarkable thrombolytic properties, effectively restoring blood flow in occluded vessels. Its rapid onset of action and reliable efficacy make it an invaluable asset in emergency situations, where prompt clot dissolution is imperative.
Furthermore, the Recombinant Human TPA/PLAT Protein boasts an excellent safety profile, minimizing the risk of adverse events commonly associated with thrombolytic therapy. Its recombinant nature ensures a consistent and reliable supply, eliminating concerns regarding batch-to-batch variability.
This product is meticulously manufactured in state-of-the-art facilities, adhering to stringent quality control measures and regulatory guidelines. Each batch undergoes rigorous testing to guarantee its purity, potency, and sterility, ensuring utmost safety and efficacy for patients.
The Recombinant Human TPA/PLAT Protein is supplied in a convenient lyophilized form, allowing for easy reconstitution and administration. Its stability and extended shelf life make it a reliable choice for healthcare professionals, ensuring optimal patient care.
In conclusion, the Recombinant Human TPA/PLAT Protein represents a groundbreaking advancement in the field of protein therapeutics. With its unrivaled thrombolytic properties, exceptional safety profile, and reliable supply, it stands as a beacon of hope for patients suffering from thrombotic disorders. Embrace this revolutionary product and witness the transformative impact it can have on patient outcomes.
The Recombinant Human TPA/PLAT Protein is a potent activator of the fibrinolytic system, specifically targeting the conversion of plasminogen to plasmin. This enzymatic activity plays a crucial role in the dissolution of blood clots, making it an indispensable tool in the treatment of thrombotic disorders.
With its exceptional specificity and affinity for fibrin, this protein exhibits remarkable thrombolytic properties, effectively restoring blood flow in occluded vessels. Its rapid onset of action and reliable efficacy make it an invaluable asset in emergency situations, where prompt clot dissolution is imperative.
Furthermore, the Recombinant Human TPA/PLAT Protein boasts an excellent safety profile, minimizing the risk of adverse events commonly associated with thrombolytic therapy. Its recombinant nature ensures a consistent and reliable supply, eliminating concerns regarding batch-to-batch variability.
This product is meticulously manufactured in state-of-the-art facilities, adhering to stringent quality control measures and regulatory guidelines. Each batch undergoes rigorous testing to guarantee its purity, potency, and sterility, ensuring utmost safety and efficacy for patients.
The Recombinant Human TPA/PLAT Protein is supplied in a convenient lyophilized form, allowing for easy reconstitution and administration. Its stability and extended shelf life make it a reliable choice for healthcare professionals, ensuring optimal patient care.
In conclusion, the Recombinant Human TPA/PLAT Protein represents a groundbreaking advancement in the field of protein therapeutics. With its unrivaled thrombolytic properties, exceptional safety profile, and reliable supply, it stands as a beacon of hope for patients suffering from thrombotic disorders. Embrace this revolutionary product and witness the transformative impact it can have on patient outcomes.
Share
